Biopharmaceutical manufacturers often implement corrective and preventive actions (CAPAs) as a mitigation strategy to address deviations based on root causes identified in investigations of process ...

Zuwei Jin, VP of Business Development at LISURE explains the advantages of the M++ system at BioProcess International US West 2025 in San Diego, CA. M++ is a pilot-scale modular benchtop system that ...

In this informative white paper, WuXi Biologics delves into how WuXi Biologics addressed the critical need for speed in moving biologics from DNA to Investigational New Drug (IND) application ...

Join our 70,000+ readers. And yes, it's completely free.

Ingress of carbon dioxide into bulk drug substance (BDS) containers that are stored and shipped on dry ice is a serious and often understated problem. Bottles are a container of choice for freezing ...

This webcast features: Sam Zhang, Vice President, Head of MVP Site,Microbial, RNA, HEK293 Platforms, WuXi Biologics. Typically, scientists use CHO cells to produce antibody-based therapeutics and ...

In vitro transcription (IVT), the enzymatic process used for the production of mRNA vaccines, differentiates itself from biological fermentation processes by the need for linearized plasmid DNA. The ...

The COVID-19 pandemic brought into focus the impact that mRNA technology can have on rapid drug development. mRNA is an attractive modality to work with because of its relative simplicity compared to ...

Cell and gene therapies have reached clinical and commercial success as evidenced by the steady number of first approvals over the past four years. Drug developers face mounting challenges linked to ...

As the gene and cell therapy market continues to expand, affordability and accelerated turnaround time (TAT) become increasingly important in the industry. Despite the escalating diversity of ...

This interview features: Tracy Kinjerski, Vice President and General Manager, Comprehensive Cell Solutions, from Cell & Gene Manufacturing and Commercialization US 2023.

Mitochondria originated millions of years ago, likely when a eukaryotic cell incorporated a bacterium. Thus, mitochondrial DNA strands are 200,000× smaller than those from a cell’s nucleus. Depending ...